Abstract | AIMS: METHODS AND RESULTS: We performed a retrospective analysis of 248 patients undergoing TAVI. AKI was defined as a VARC-modified Risk, Injury, Failure, Loss, and End-stage (RIFLE) kidney disease score ≥ 2. Eighty-nine patients suffered AKI (35.9%) and demonstrated increased mortality at 30 days (13.5% vs. 3.8%) and one year (31.5% vs. 15.0%) (p<0.001). Multivariate regression analysis identified diabetes mellitus (p<0.001), peripheral vascular disease (p=0.007), chronic kidney disease stage (p=0.010) as independently associated risk factors for AKI. CONCLUSIONS:
|
Authors | Muhammed Zeeshan Khawaja, Martyn Thomas, Abhishek Joshi, Kaleab N Asrress, Karen Wilson, Kirsty Bolter, Christopher P Young, Jane Hancock, Vinayak Bapat, Simon Redwood |
Journal | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
(EuroIntervention)
Vol. 8
Issue 5
Pg. 563-70
(Sep 2012)
ISSN: 1969-6213 [Electronic] France |
PMID | 22995082
(Publication Type: Journal Article)
|
Topics |
- Acute Kidney Injury
(epidemiology, etiology, mortality)
- Aged
- Aged, 80 and over
- Aortic Valve
(surgery)
- Bioprosthesis
- Cardiac Catheterization
- Female
- Heart Valve Prosthesis Implantation
(adverse effects)
- Humans
- Logistic Models
- Male
- Retrospective Studies
- Risk Factors
|